{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:27:12Z","timestamp":1786994832680,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["0021310"],"award-info":[{"award-number":["0021310"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.neurobiolaging.2010.02.016","type":"journal-article","created":{"date-parts":[[2010,4,1]],"date-time":"2010-04-01T04:37:57Z","timestamp":1270096677000},"page":"226-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease"],"prefix":"10.1016","volume":"33","author":[{"given":"Fabrizio","family":"Piazza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Galimberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Isella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria V.","family":"Perlangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Speranza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Borroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico M.","family":"Pogliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Padovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Ferrarese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/01.mbc.0000245294.41774.06","article-title":"The tissue factor pathway in ischemic stroke","volume":"17","author":"Adams","year":"2006","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib4","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/00002093-200207000-00004","article-title":"Peripheral blood abnormalities in Alzheimer disease: evidence for early endothelial dysfunction","volume":"16","author":"Borroni","year":"2002","journal-title":"Alzheimer Dis. Assoc. Disord"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.7326\/0003-4819-131-5-199909070-00006","article-title":"Nonfasting plasma total homocysteine levels and stroke incidence in elderly persons: the Framingham Study","volume":"131","author":"Bostom","year":"1999","journal-title":"Ann. Intern. Med"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib6","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1161\/ATVBAHA.108.177402","article-title":"Tissue factor in coagulation","volume":"29","author":"Butenas","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib7","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1161\/STROKEAHA.108.516575","article-title":"Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study","volume":"39","author":"Das","year":"2008","journal-title":"Stroke"},{"issue":"Suppl 1","key":"10.1016\/j.neurobiolaging.2010.02.016_bib8","doi-asserted-by":"crossref","first-page":"S72","DOI":"10.1097\/00002093-200000001-00012","article-title":"Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease","volume":"14","author":"De La Torre","year":"2000","journal-title":"Alzheimer Dis. Assoc. Disord"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib9","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.20516","article-title":"Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?","volume":"57","author":"De La Torre","year":"2005","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0022-510X(96)00249-3","article-title":"The apolipoprotein E epsilon4 allele causes a faster decline of cognitive performances in Down's syndrome subjects","volume":"145","author":"Del Bo","year":"1997","journal-title":"J. Neurol. Sci"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1056\/NEJM199603213341203","article-title":"Hyperhomocysteinemia as a risk factor for deep-vein thrombosis","volume":"334","author":"den Heijer","year":"1996","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.neurobiolaging.2006.10.007","article-title":"B-vitamins reduce plasma levels of beta amyloid","volume":"29","author":"Flicker","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/archneur.56.1.33","article-title":"Diagnostic criteria for Parkinson disease","volume":"56","author":"Gelb","year":"1999","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1113\/expphysiol.2007.038729","article-title":"Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease","volume":"93","author":"Hamel","year":"2008","journal-title":"Exp. Physiol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib15","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1093\/brain\/awg040","article-title":"Markers of endothelial dysfunction in lacunar infarction and ischaemic leukoaraiosis","volume":"126","author":"Hassan","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0006-8993(96)00384-8","article-title":"Immunohistochemical localization of tissue factor pathway inhibitor-1 (TFPI-1), a Kunitz proteinase inhibitor, in Alzheimer's disease","volume":"728","author":"Hollister","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib18","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrn1387","article-title":"Neurovascular regulation in the normal brain and in Alzheimer's disease","volume":"5","author":"Iadecola","year":"2004","journal-title":"Nat. Rev"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00401-006-0185-2","article-title":"The enigma of vascular cognitive disorder and vascular dementia","volume":"113","author":"Jellinger","year":"2007","journal-title":"Acta Neuropathol"},{"issue":"suppl 3","key":"10.1016\/j.neurobiolaging.2010.02.016_bib20","doi-asserted-by":"crossref","first-page":"S115","DOI":"10.1097\/00002093-199912003-00017","article-title":"Overlap between pathology of Alzheimer disease and vascular dementia","volume":"13","author":"Kalaria","year":"1999","journal-title":"Alzheimer Dis. Assoc. Disord"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1182\/blood-2005-06-2506","article-title":"Elevated levels of homocysteine compromise blood\u2013brain barrier integrity in mice","volume":"107","author":"Kamath","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib22","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/jada.2003.50083","article-title":"Homocysteine and Alzheimer's disease","volume":"103","author":"Leboeuf","year":"2003","journal-title":"J. Am. Diet. Assoc"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1159\/000071002","article-title":"Vitamin B12-B6-folate treatment improves blood\u2013brain barrier function in patients with hyperhomocysteinaemia and mild cognitive impairment","volume":"16","author":"Lehmann","year":"2003","journal-title":"Dement. Geriatr. Cognit. Disord"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/path.1871","article-title":"Tissue factor pathway inhibitor: structure, biology and involvement in disease","volume":"208","author":"Lwaleed","year":"2006","journal-title":"J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib25","first-page":"491","article-title":"Tissue factor antigen in senile plaques of Alzheimer's disease","volume":"139","author":"McComb","year":"1991","journal-title":"Am. J. Pathol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib26","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib27","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1161\/ATVBAHA.107.141911","article-title":"Role of the extrinsic pathway of blood coagulation in hemostasis and thrombosis","volume":"27","author":"Mackman","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib28","first-page":"366","article-title":"TFPI antigen and activity levels in patients with asymptomatic atherosclerosis and target organ acute and chronic complications","volume":"24","author":"Novo","year":"2005","journal-title":"Int. Angiol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib29","doi-asserted-by":"crossref","first-page":"18832","DOI":"10.1016\/S0021-9258(18)51542-8","article-title":"Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma","volume":"264","author":"Novotny","year":"1989","journal-title":"J. Biol. Chem"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib30","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1182\/blood.V97.12.3721","article-title":"Regulation of monocyte procoagulant activity in acute myocardial infarction: role of tissue factor and tissue factor pathway inhibitor-1","volume":"97","author":"Ott","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib31","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0140-6736(95)92407-8","article-title":"Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men","volume":"346","author":"Perry","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib32","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1001\/archneur.56.3.303","article-title":"Mild cognitive impairment: clinical characterization and outcome","volume":"56","author":"Petersen","year":"1999","journal-title":"Arch. Neurol"},{"issue":"suppl 4","key":"10.1016\/j.neurobiolaging.2010.02.016_bib33","first-page":"154","article-title":"Tissue factor pathway inhibitor (TFPI) \u2212 an update","volume":"26","author":"Sandset","year":"1996","journal-title":"Haemostasis"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199502023320502","article-title":"Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis","volume":"332","author":"Selhub","year":"1995","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib35","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3233\/JAD-2006-9404","article-title":"Elevated plasma homocysteine levels: risk factor or risk marker for the development of dementia and Alzheimer's disease?","volume":"9","author":"Seshadri","year":"2006","journal-title":"J. Alzheimers Dis"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer's disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib37","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archneur.65.5.642","article-title":"Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study","volume":"65","author":"Seshadri","year":"2008","journal-title":"Arch. Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib38","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0197-4580(00)00119-6","article-title":"Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease","volume":"21","author":"Shi","year":"2000","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1046\/j.1365-2362.2002.00971.x","article-title":"Effect of homocysteine on arachidonic acid release in human platelets","volume":"32","author":"Signorello","year":"2002","journal-title":"Eur. J. Clin. Invest"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib40","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1212\/01.wnl.0000341272.48617.b0","article-title":"Biochemical indicators of vitamin B(12) and folate insufficiency and cognitive decline","volume":"72","author":"Tangney","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib41","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/380168a0","article-title":"beta-Amyloid-mediated vasoactivity and vascular endothelial damage","volume":"380","author":"Thomas","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib42","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/01.STR.27.11.2069","article-title":"Alterations of the blood\u2013brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients","volume":"27","author":"Tomimoto","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib43","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ana.21073","article-title":"Atherosclerosis and risk for dementia","volume":"61","author":"van Oijen","year":"2007","journal-title":"Ann. Neurol"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib44","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1056\/NEJM199804093381507","article-title":"Homocysteine and atherothrombosis","volume":"338","author":"Welch","year":"1998","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib45","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.tins.2005.02.001","article-title":"Neurovascular mechanisms of Alzheimer's neurodegeneration","volume":"28","author":"Zlokovic","year":"2005","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurobiolaging.2010.02.016_bib46","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","article-title":"The blood\u2013brain barrier in health and chronic neurodegenerative disorders","volume":"57","author":"Zlokovic","year":"2008","journal-title":"Neuron"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458010001077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458010001077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:18:26Z","timestamp":1759317506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458010001077"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":44,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0197458010001077"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.02.016","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}